Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check12 days agoChange DetectedAn NIH-wide notice about website updates and a shift in terminology from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error page for the study record, instead of listing study details; a Home link is shown as part of the default error page.SummaryDifference22%

- Check46 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, signaling a small internal update to the page rather than a substantive change to study details or results.SummaryDifference0.0%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.